SMA Research Platform

Evidence graph for Spinal Muscular Atrophy

Biology-first target discovery
Christian Fischer / Bryzant Labs
15,934Targets
453Trials
84Drugs
7Datasets
7,947Sources
226,991Claims
263,546Evidence
58,010Hypotheses
DRUGpreclinicalsmall molecule

e1-1022

Mechanism

Preclinical SMA therapeutic candidate. Dual molecule approach.

Related claims (0)

No claims matched “e1-1022” in free-text search.

Off-Target Findings (0)

No Boltz-2 / Chai-1 off-target panel claims recorded for this drug.

Login → Command Center